Long-term outcome of pediatric renal transplantation: A single center experience

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages 388-394

  Abe, Toyofumi ^a   Ichimaru, Naotsugu ^a   Kakuta, Yoichi ^a   Okumi, Masayoshi ^a   Imamura, Ryoichi ^a   Isaka, Yoshitaka ^a   Takahara, Shiro ^a   Kokado, Yukito ^b   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Takahashi Clinic   (Japan)

Author keywords

Growth; Kidney transplantation; Long term outcome; Pediatric

Indexed keywords

CALCINEURIN;

ADOLESCENT; ADULT; ARTICLE; BODY GROWTH; BODY HEIGHT; CHILD; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958738883     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01250.x     Document Type: Article

References (25)

1. Seikaly M, Ho PL, Emmett L, Tejani A. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant 2001: 5: 215.
2. Goldstein SL, Graham N, Burwinkle T, Warady B, Farrah R, Varni JW. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol 2006: 21: 846.
3. McDonald SP, Craig JC; Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med 2004: 350: 2654.
4. Shishido S, Asanuma H, Tajima E et al. ABO-incompatible living-donor kidney transplantation in children. Transplantation 2001: 72: 1037.
5. Broyer M, Brunner FP, Brynger H et al. Kidney transplantation in primary oxalosis: data from the EDTA Registry. Nephrol Dial Transplant 1990: 5: 332.
6. Leumann E, Hoppe B. The primary hyperoxaluria. J Am Soc Nephrol 2001: 12: 1986.
7. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Annual Report 2006.
8. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Annual Report 2004.
9. Humar A, Arrazola L, Mauer M, Matas AJ, Najarian JS. Kidney transplantation in young children: should there be a minimum age? Pediatr Nephrol 2001: 16: 941.
10. Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation 2000: 69: 1414.
11. Jarzembowski T, John E, Panaro F et al. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 2004: 8: 367.
12. Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002: 6: 396.
13. Coutinho HM, Groothoff JW, Offringa M, Gruppen MP, Heymans HS. De novo malignancy after paediatric renal replacement therapy. Arch Dis Child 2001: 85: 478.
14. Nissel R, Brazda I, Feneberg R et al. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int 2004: 66: 792.
15. Jabs K, Sullivan EK, Avner ED, Harmon WE. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1996: 61: 31.
16. Motoyama O, Hasegawa A, Ohara T et al. A prospective trial of steroid cessation after renal transplantation in pediatric patients treated with cyclosporine and mizoribine. Pediatr Transplant 1997: 1: 29.
17. Chakrabarti P, Wong HY, Scantlebury VP et al. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 2000: 70: 760.
18. Hocker B, John U, Plank C et al. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation 2004: 78: 228.
19. Koshiba T, Van Damme B, Ji P et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion. Transplant Proc 2001: 33: 375.
20. Wang C, Sun J, Sheil AG, Mccaughan GW, Bishop GA. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001: 72: 44.
21. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra OJR. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331.
22. Roelfsema V, Clark RG. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 2001: 12: 1297.
23. Fine RN, Stablein D. Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol 2005: 20: 404.
24. Melk A, Daniel V, Mehls O, Opelz G, Tonshoff B. Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy. Transplantation 2004: 78: 1792.
25. Mehls O, Wilton P, Lilien M et al. Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol 2002: 17: 984.